http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2660051-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f79749e86afce9444a364ab60ca3584
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a41ed49eaf3843ffdc00cdd622542ee2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac0e0db817d9fb8da61d7a37abf3fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a08a75627db1527c3b78414a13432167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b16b25b401d658fc3079d3d8ca5bbb
publicationDate 2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2660051-T3
titleOfInvention Heterocyclic compounds fused as selective inhibitors of BMP
abstract A compound that has a structure represented by the following formula (I): ** (See formula) ** in which: Y and Z are selected to form :: ** (See formula) ** in which each A1 is independently O, CR1R2, or NH, or NR1, or NR1R2 or together with another A1 forms C3-C12 cycloalkyl or C3-C12 cycloalkenyl or aryl or heteroaryl or C3-C12 heterocycloalkyl or C3-C12 heterocycloalkenyl or a 3-8 membered ring comprising C, O, S and / or N; R is selected from CF3, halogen, CN, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, NR1R2, S (O) 0-2NR1R2 or S (O) 0-2R1R2; M is substituted or unsubstituted and is selected from aryl or heteroaryl; D is selected from a bond, O, CR1R2 or NH or NR1 or NR1R2; E is selected from H, CF3, halogen, CN, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C3-C12 cycloalkyl or substituted or unsubstituted C3-C12 cycloheteroalkyl or - ( CH2) x-C3-C12 cycloalkyl or - (CH2) x-C3-C12 cycloheteroalkyl; R1 is absent or selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and R2 is selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or COR1, or, R1 and R2 form a C3-C12 cycloalkyl or a C3-C12 cycloheteroalkyl containing O, N or S; or a pharmaceutically acceptable salt thereof.
priorityDate 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456500829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9855439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410442037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393328

Total number of triples: 56.